Cyfuse Biomedical K.K. (TYO:4892)
Japan
· Delayed Price · Currency is JPY 711.00
+1.00 (0.14%)
Apr 28, 2026, 3:30 PM JST
Cyfuse Biomedical K.K. Market Cap
Cyfuse Biomedical K.K. has a market cap or net worth of 7.08 billion as of April 29, 2026. Its market cap has decreased by -4.78% in one year.
Market Cap
7.08B
Enterprise Value
4.67B
Revenue
230.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
711.00
Market Cap Chart
Since December 1, 2022, Cyfuse Biomedical K.K.'s market cap has decreased from 13.00B to 7.08B, a decrease of -45.52%. That is a compound annual growth rate of -16.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 7.08B | 24.92% |
| Dec 30, 2025 | 5.67B | 54.23% |
| Dec 30, 2024 | 3.68B | -38.27% |
| Dec 29, 2023 | 5.96B | -37.68% |
| Dec 30, 2022 | 9.56B | -26.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SymBio Pharmaceuticals | 6.68B |
| WDB coco | 6.27B |
| Nippon Chemiphar | 6.10B |
| Morishita Jintan | 9.10B |
| Modalis Therapeutics | 5.28B |
| Solasia Pharma K.K. | 9.56B |
| MedRx | 4.81B |
| Wakamoto Pharmaceutical | 12.14B |